Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer

Gastroenterology

Volumn 137, Issue 2, 2009, Pages

  Biankin, Andrew V ^a,b   Kench, James G ^a,c   Colvin, Emily K ^a   Segara, Davendra ^a,b,d   Scarlett, Christopher J ^a   Nguyen, Nam Q ^a,e   Chang, David K ^a,b   Morey, Adrienne L ^d   Lee, C Soon ^c   Pinese, Mark ^a   Kuo, Samuel C L ^a   Susanto, Johana M ^a   Cosman, Peter H ^a,b   Lindeman, Geoffrey J ^f   Visvader, Jane E ^f   Nguyen, Tuan V ^a   Merrett, Neil D ^a,b   Warusavitarne, Janindra ^a,b   Musgrove, Elizabeth A ^a   Henshall, Susan M ^a   Sutherland, Robert L ^a   more..

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; PROTEIN HOXB2; PROTEIN S100A2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS RESECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

EID: 67650935823     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.04.009     Document Type: Article

References (30)

1. Neoptolemos J.P., Dunn J.A., Stocken D.D., et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358 (2001) 1576-1585
2. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
3. Nitecki S.S., Sarr M.G., Colby T.V., et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?. Ann Surg 221 (1995) 59-66
4. Sperti C., Pasquali C., Piccoli A., et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83 (1996) 625-631
5. Millikan K.W., Deziel D.J., Silverstein J.C., et al. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 65 (1999) 618-624
6. Benassai G., Mastrorilli M., Quarto G., et al. Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 73 (2000) 212-218
7. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4 (2000) 567-579
8. Brennan M.F., Kattan M.W., Klimstra D., et al. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240 (2004) 293-298
9. Raut C.P., Tseng J.F., Sun C.C., et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246 (2007) 52-60
10. Garcea G., Neal C.P., Pattenden C.J., et al. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 41 (2005) 2213-2236
11. Biankin A.V., Morey A.L., Lee C.-S., et al. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J Clin Oncol 20 (2002) 4531-4542
12. Murphy N.M., Scarlett C.J., Kench J.G., et al. LMO4 expression and outcome in pancreatic ductal adenocarcinoma. Br J Cancer 98 (2008) 537-541
13. Pasca di Magliano M., Biankin A.V., Heiser P.W., et al. Common activation of canonical wnt signaling in pancreatic adenocarcinoma. PLoS One 2 (2007) e1155
14. Skalicky D.A., Kench J.G., Segara D., et al. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 15 (2006) 1941-1947
15. Segara D., Biankin A.V., Kench J.G., et al. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res 11 (2005) 3587-3596
16. Sum E.Y., O'Reilly L.A., Jonas N., et al. The LIM domain protein LMO4 is highly expressed in proliferating mouse epithelial tissues. J Histochem Cytochem 53 (2005) 475-486
17. Iacobuzio-Donahue C.A., Ashfaq R., Maitra A., et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63 (2003) 8614-8622
18. Grutzmann R., Pilarsky C., Ammerpohl O., et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6 (2004) 611-622
19. Logsdon C.D., Simeone D.M., Binkley C., et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63 (2003) 2649-2657
20. McCarty Jr. K.S., Miller L.S., Cox E.B., et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109 (1985) 716-721
21. Brenton J.D., Carey L.A., Ahmed A.A., et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol 23 (2005) 7350-7360
22. Ohuchida K., Mizumoto K., Miyasaka Y., et al. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. J Pathol 213 (2007) 275-282
23. Schniewind B., Bestmann B., Henne-Bruns D., et al. Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg 93 (2006) 1099-1107
24. Mahon P.C., Baril P., Bhakta V., et al. S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res 67 (2007) 6786-6795
25. Bulk E., Sargin B., Krug U., et al. S100A2 induces metastasis in nonsmall cell lung cancer. Clin Cancer Res 15 (2009) 22-29
26. Suemizu H., Monnai M., Ohnishi Y., et al. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/γcnull (NOG) mice. Int J Oncol 31 (2007) 741-751
27. Garrett S.C., Hodgson L., Rybin A., et al. A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics. Biochemistry 47 (2008) 986-996
28. Lost in validation. Nat Biotechnol 24 (2006) 869
29. Stanley K.K., and Szewczuk E. Multiplexed tandem PCR: gene profiling from small amounts of RNA using SYBR Green detection. Nucleic Acids Res 33 (2005) e180
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45